438 related articles for article (PubMed ID: 16895550)
1. Beta-adrenoceptor-mediated inhibition of mediator release from human peripheral blood-derived mast cells.
Wang XS; Lau HY
Clin Exp Pharmacol Physiol; 2006 Aug; 33(8):746-50. PubMed ID: 16895550
[TBL] [Abstract][Full Text] [Related]
2. Influence of receptor reserve on beta-adrenoceptor-mediated responses in human lung mast cells.
Drury DE; Chong LK; Ghahramani P; Peachell PT
Br J Pharmacol; 1998 Jun; 124(4):711-8. PubMed ID: 9690863
[TBL] [Abstract][Full Text] [Related]
3. Salmeterol inhibition of mediator release from human lung mast cells by beta-adrenoceptor-dependent and independent mechanisms.
Chong LK; Cooper E; Vardey CJ; Peachell PT
Br J Pharmacol; 1998 Mar; 123(5):1009-15. PubMed ID: 9535032
[TBL] [Abstract][Full Text] [Related]
4. Desensitisation of mast cell beta2-adrenoceptor-mediated responses by salmeterol and formoterol.
Scola AM; Chong LK; Suvarna SK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Jan; 141(1):163-71. PubMed ID: 14662724
[TBL] [Abstract][Full Text] [Related]
5. Desensitization of beta2-adrenoceptor-mediated responses by short-acting beta2-adrenoceptor agonists in human lung mast cells.
Chong LK; Suvarna K; Chess-Williams R; Peachell PT
Br J Pharmacol; 2003 Feb; 138(3):512-20. PubMed ID: 12569076
[TBL] [Abstract][Full Text] [Related]
6. Differential effects of beta2-adrenoceptor desensitization on the IgE-dependent release of chemical mediators from cultured human mast cells.
Tsuji T; Kato T; Kimata M; Miura T; Serizawa I; Inagaki N; Nagai H
Biol Pharm Bull; 2004 Oct; 27(10):1549-54. PubMed ID: 15467193
[TBL] [Abstract][Full Text] [Related]
7. Pharmacological characterisation of the beta-adrenoceptor expressed by human lung mast cells.
Chong LK; Chess-Williams R; Peachell PT
Eur J Pharmacol; 2002 Feb; 437(1-2):1-7. PubMed ID: 11864632
[TBL] [Abstract][Full Text] [Related]
8. Role of beta2-adrenoceptors (beta-AR), but not beta1-, beta3-AR and endothelial nitric oxide, in beta-AR-mediated relaxation of rat intrapulmonary artery.
Pourageaud F; Leblais V; Bellance N; Marthan R; Muller B
Naunyn Schmiedebergs Arch Pharmacol; 2005 Jul; 372(1):14-23. PubMed ID: 16133491
[TBL] [Abstract][Full Text] [Related]
9. The effects of anti-asthma drugs on mediator release from cultured human mast cells.
Shichijo M; Inagaki N; Nakai N; Kimata M; Nakahata T; Serizawa I; Iikura Y; Saito H; Nagai H
Clin Exp Allergy; 1998 Oct; 28(10):1228-36. PubMed ID: 9824389
[TBL] [Abstract][Full Text] [Related]
10. Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell.
Undem BJ; Peachell PT; Lichtenstein LM
J Pharmacol Exp Ther; 1988 Oct; 247(1):209-17. PubMed ID: 2459368
[TBL] [Abstract][Full Text] [Related]
11. Protection by dexamethasone of the functional desensitization to beta 2-adrenoceptor-mediated responses in human lung mast cells.
Chong LK; Drury DE; Dummer JF; Ghahramani P; Schleimer RP; Peachell PT
Br J Pharmacol; 1997 Jun; 121(4):717-22. PubMed ID: 9208139
[TBL] [Abstract][Full Text] [Related]
12. Influence of agonist intrinsic activity on the desensitisation of beta2-adrenoceptor-mediated responses in mast cells.
Scola AM; Chong LK; Chess-Williams R; Peachell PT
Br J Pharmacol; 2004 Sep; 143(1):71-80. PubMed ID: 15289287
[TBL] [Abstract][Full Text] [Related]
13. The effects of S1319, a novel marine sponge-derived beta2-adrenoceptor agonist, on IgE-mediated activation of human cultured mast cells.
Suzuki H; Ueno A; Takei M; Shindo K; Higa T; Fukamachi H
Inflamm Res; 2000 Feb; 49(2):86-94. PubMed ID: 10738947
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol.
Church MK; Hiroi J
Br J Pharmacol; 1987 Feb; 90(2):421-9. PubMed ID: 2435353
[TBL] [Abstract][Full Text] [Related]
15. Anti-inflammatory effect of beta 2-agonists: inhibition of TNF-alpha release from human mast cells.
Bissonnette EY; Befus AD
J Allergy Clin Immunol; 1997 Dec; 100(6 Pt 1):825-31. PubMed ID: 9438493
[TBL] [Abstract][Full Text] [Related]
16. The human recombinant c-kit receptor ligand, rhSCF, induces mediator release from human cutaneous mast cells and enhances IgE-dependent mediator release from both skin mast cells and peripheral blood basophils.
Columbo M; Horowitz EM; Botana LM; MacGlashan DW; Bochner BS; Gillis S; Zsebo KM; Galli SJ; Lichtenstein LM
J Immunol; 1992 Jul; 149(2):599-608. PubMed ID: 1378071
[TBL] [Abstract][Full Text] [Related]
17. beta(2) and beta(3)-adrenoceptor inhibition of alpha(1)-adrenoceptor-stimulated Ca(2+) elevation in human cultured prostatic stromal cells.
Haynes JM
Eur J Pharmacol; 2007 Sep; 570(1-3):18-26. PubMed ID: 17617401
[TBL] [Abstract][Full Text] [Related]
18. Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung.
Butchers PR; Vardey CJ; Johnson M
Br J Pharmacol; 1991 Nov; 104(3):672-6. PubMed ID: 1724629
[TBL] [Abstract][Full Text] [Related]
19. Influence of beta2-adrenoceptor gene polymorphisms on beta2-adrenoceptor-mediated responses in human lung mast cells.
Kay LJ; Rostami-Hodjegan A; Suvarna SK; Peachell PT
Br J Pharmacol; 2007 Oct; 152(3):323-31. PubMed ID: 17643132
[TBL] [Abstract][Full Text] [Related]
20. Pharmacological characteristics of BDTI, a new isoquinoline-derived beta 2-adrenoceptor agonist, in canine trachea and rat heart.
Lin CH; Yang CM; Chen CM; Ko FN; Teng CM
Pharmacology; 1996 Jul; 53(1):19-27. PubMed ID: 8875598
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
